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Neglected Diseases, University of Notre Dame, Notre Dame, IndianaABSTRACT Ebola virus assembles and buds from the inner leaflet of the plasma membrane of mammalian cells, which is
primarily attributed to its major matrix protein VP40. Oligomerization of VP40 has been shown to be essential to the life cycle
of the virus including formation of virions from infected cells. To date, VP40 oligomerization has mainly been assessed by chem-
ical cross-linking following cell fractionation studies with VP40 transfected cells. This has made it difficult to discern the spatial
and temporal dynamics of VP40 oligomerization. To gain a better understanding of the VP40 assembly and oligomerization
process in live cells, we have employed real-time imaging of enhanced green fluorescent protein tagged VP40. Here, we use
both confocal and total internal reflection microscopy coupled with number and brightness analysis to show that VP40 oligomers
are localized on the plasma membrane and are highly enriched at sites of membrane protrusion, consistent with sites of viral
budding. These filamentous plasma membrane protrusion sites harbor VP40 hexamers, octamers, and higher order oligomers.
Consistent with previous reports, abrogation of VP40 oligomerization through mutagenesis greatly diminished VP40 egress and
also abolished membrane protrusion sites enriched with VP40. In sum, real-time single-molecule imaging of fluorescently
labeled Ebola VP40 is able to resolve the spatial and temporal dynamics of VP40 oligomerization.INTRODUCTIONViral hemorrhagic fevers including those stemming from the
Ebola virus pose a serious public health threat in central and
eastern Africa with fatality rates as high as 90% (1–4). Thus
far, there are no FDA approved vaccines or therapeutics to
treat or prevent Ebola infections and hence Ebola is classi-
fied as a biosafety level 4 (BSL-4) agent (5). In addition to
the aforementioned outbreaks in humans there have been
incidences of Ebola transmitted in animal facilities in the
United States but without human fatalities (6). With the
growing threat of bioterrorism, Ebola virus represents a bio-
logical agent that could be weaponized by terrorists; hence,
the urgent need to identify therapeutic targets (7–9).
The Ebola virus uses a negative sense RNA genome en-
coding seven proteins to replicate in the host cell (10,11).
The nucleoprotein, VP30, VP35, and L protein constitute
the nucleocapsid (NC), which is critical for transcription
and viral replication (11). The glycoprotein is rooted in
the lipid envelope of the virus and is responsible for entry
of virions into cells (12). VP40 and VP24 are the matrix
proteins of the virus and are important for budding as well
as virus structure and stability (7,10,13,14). VP40 (see
Fig. 1 A) is the major matrix protein and the most abundant
protein of the virus, which plays a central role in the budding
of the virus from the plasma membrane. For example,
expression of VP40 alone in mammalian cells assembles
into virus-like particles (VLPs) that have similar character-Submitted January 30, 2012, and accepted for publication April 17, 2012.
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studies have shown that in the absence of VP40, the nucle-
ocapsid is not effectively transported to the plasma
membrane, the site of assembly and budding, where it is
incorporated into the virions (17). Therefore, understanding
how VP40 regulates assembly of VLPs both in vitro and in
live cells is critical for identifying therapeutic targets for
inhibiting the replication and spread of the virus (7). The
assembly of VLPs by Ebola VP40 also represents an attrac-
tive model for studying the assembly of the virus in a BSL-2
setting because the VLPs are noninfectious.
Progress has been made in understanding how VP40
forms VLPs. For example, VP40 associates with the plasma
membrane (18) where it presumably initiates assembly.
Additionally, host factors such as the ESCRT machinery
(15,19) as well as COPII proteins (20,21) have been impli-
cated in the budding and transport of VP40, respectively.
However, how the virus assembles on the plasma membrane
before virion release remains poorly understood. Oligomer-
ization of VP40 is thought to be an important step in this
process as studies have shown that VP40 oligomerizes
both in the cell (18,22,23) and in solution (24). Moreover,
VP40 oligomers have been detected in VLPs and ultravi-
olet-inactivated virions (18,25). VP40 has primarily been
shown to oligomerize into hexamers and octamers
(22–25), which share a similar intradimeric (monomer-
monomer interface) antiparallel interface (see Fig. 1 B)
(26). Although these studies have contributed to our under-
standing of VP40 behavior, it is difficult to predict the olig-
omerization dynamics of VP40 in cells from these studies.doi: 10.1016/j.bpj.2012.04.022
FIGURE 1 Structure of VP40 and VP40 intradimeric interface. VP40
consists of an N-terminal domain (gray) that has been shown to be involved
in oligomerization and a C-terminal domain (raspberry) that has been
deemed important for membrane binding. (A) VP40 x-ray structure
(PDB: 1ES6) with the N-terminal domain and C-terminal domain colored
in gray and raspberry, respectively. Purported residues involved in oligo-
merization are highlighted: Trp95 (cyan), Arg148 and Arg149 (blue),
Glu160 (red), and Glu184 (magenta). (B) Antiparallel monomeric-mono-
meric interface (intradimeric interface with one monomer in dark gray
and the second monomer in light gray) highlighting the Glu160 (red) inter-
action with Arg148 and Arg149 (blue), and the Trp95 (cyan) interaction with
Glu184 (magenta) (PDB: 1H2D).
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quent identification of these oligomeric structures make it
difficult to assess the true size of the oligomers in the
real-time assembly and oligomerization of VP40.
Studies have shown that VP40 oligomers are essential for
the formation of VLPs (22,27) and have been found to be
associated with detergent-resistant membranes (18), sug-
gesting that the plasma membrane may play an important
role in the oligomerization of VP40. Oligomerization of
the matrix protein on the plasma membrane may serve as
a scaffold to recruit host proteins as well as provide the
necessary force to bring about membrane deformation and
virus particle formation (28,29). Thus, understanding the
spatial and temporal dynamics of VP40 oligomerization is
critical to unraveling how the virus buds form at the plasma
membrane. Furthermore, the origin of these oligomers is
still unclear and it is not known whether VP40 oligomers
are recruited from the cytoplasm or an intracellular mem-
brane to the site of budding. Therefore, the analysis of
formation of VP40 oligomers in live cells would provide
keen insight into the spatial and temporal architecture of
VP40 assembly.
In this report, we have resolved the oligomerization state
of VP40 in live cells by a combination of total internal
reflection (TIRF) microscopy and the number and bright-
ness (N&B) analysis (30–32) developed at the Laboratory
for Fluorescence Dynamics (www.lfd.uci.edu). This method
is noninvasive and is best suited to study assembly at theBiophysical Journal 102(11) 2517–2525plasma membrane as molecules that are on the plasma
membrane are selectively illuminated (31,33). The studies
reveal that the assembly of VP40 is dynamic as monomeric
VP40 is recruited from the cytosol to the plasma membrane
where VP40 oligomers are observed. In addition, N&B
analysis was able to resolve VP40 oligomerization
associated with sites of membrane protrusion. This study
highlights the value of the N&B approach coupled with
TIRF microscopy in defining the oligomeric state of cyto-
solic and membrane bound viral matrix proteins.MATERIALS AND METHODS
Plasmids
The mammalian expression plasmid for VP40 was created by subcloning
VP40 into enhanced green fluorescent protein (EGFP)-pcDNA3.1 using
EcoRI and XhoI restriction sites with standard cloning methods.Cell culture
Human embryonic kidney (HEK293T) cells were cultured and maintained
at 37C in a 5% CO2 humidified incubator supplemented with Dulbecco’s
modified Eagle’s medium (low glucose) containing 10% fetal bovine serum
and 1% Pen/Strep. After trypsinization, cells were transferred from a T-25
tissue culture flask to a 35 mm glass bottom microwell dish coated with
1–2 mg/ml fibronectin (MatTek, Ashland, MA). Cells were then grown to
50–80% confluency and transfected with 1 mg DNA/dish using lipofect-
amine 2000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s
protocol.RICS data acquisition
Fluorescence intensity fluctuations within the focal volume of a live cell can
be attributed to protein binding to immobile or less mobile fractions, protein
conformation changes, and the entry and exit of molecules through the focal
volume. Raster image correlation spectroscopy (RICS) is the ideal method
for measuring these processes as the scanning movement creates a space-
time matrix of pixels within each image. On commercial confocal micro-
scopes the spatial and temporal sampling time of the laser beam (pixel
dwell time) is known as is the scan time between scan lines and time
between images. Thus, using RICS allows for a generation of spatial-
temporal maps of dynamics occurring across the living cell. RICS data
were acquired on a commercial laser scanning confocal microscope (Zeiss
LSM710 inverted microscope) using a Plan Apochromat 63 1.4 NA oil
objective. The 488 nm line of the Ar ion laser was used for excitation of
EGFP. The laser power was maintained at 1% throughout the experiment
with the emission collected through a 493–556 nm filter. The data
were collected as images of 256  256 pixels with a pixel dwell time of
12.6 ms. RICS analysis was done with SimFCS software (Laboratory for
Fluorescence Dynamics) using 100 frames of the image series.TIRF imaging
TIRF imaging was performed using a homebuilt TIRF imaging system
(model No. IX81 microscope (Olympus, Melville, NY) as described previ-
ously (33). Briefly, images were collected using a Cascade 512B EMCCD
camera. Samples were illuminated with the 488 nm line from an Ar ion
laser (Melles Griot, Albuquerque, NM) through a 60, 1.45 NA oil objec-
tive (Olympus). To ensure cell integrity, cells were maintained at 37C
using a thermostated stage (Tokai Hit, Shizuoka, Japan). Images were
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total frames were collected. Images were saved as 16 bit unsigned and im-
ported into the SimFCS software (Laboratory for Fluorescence Dynamics).Data analysis
TIRF image series were analyzed using SimFCS (Laboratory for Fluores-
cence Dynamics). For N&B analysis, 512 frames were analyzed per image
series. HEK293T cells expressing monomeric EGFP, a brightness standard,
were imaged under the same conditions as EGFP-VP40 and respective
mutations. The brightness of the EGFP was used as the brightness of the
monomer. The selection window for analysis in the brightness versus inten-
sity plot was based on the average brightness of a monomer (0.104), which
allowed for selection of oligomeric size based upon multiple of the mono-
mer. Thus, the selection window for each species is based upon the average
brightness, which will yield an average population of each species in the
respective area of analysis.TIRF microscopy and N&B analysis
Determination of the average number and brightness of fluorescent mole-
cules in live cells is a challenging task but an important one as many
biological processes often depend upon protein clustering. Recently, deter-
mination of fluorescently labeled protein clustering has become much more
robust with N&B analysis. N&B analysis is based upon moment analysis
and allows for measurement of the average number of molecules as well
as brightness in each pixel of a fluorescent microscopy image (31). Here,
the average brightness of a particle is determined from the ratio of vari-
ance/intensity at each pixel. Fluctuating particles can be determined by
dividing the average intensity by the brightness at each pixel. For particles
fluctuating in the focal volume, the variance is proportional to the square of
the particle brightness; however, the variance of the immobile particles and
detector noise is proportional to the intensity of these components. Thus,
only fluorescent fluctuations that are dependent upon the mobile particles
(square of the brightness) have a ratio of the variance/intensity >1. Bright-
ness maps then allow determination of the aggregation of mobile fluores-
cent particles with pixel resolution.
For the electron multiplying charge-coupled device camera the following
equations were used to compute the number and brightness.
N ¼ ðhIi  offsetÞ
2
ðs2  s20Þ
; (1)

s2  s2B ¼ 0ðhIi  offsetÞ; (2)
where N and B are the apparent number and the brightness of the molecule,
hIi is the average intensity of a pixel throughout a stack of frames (time
average), s2 is the variance, and offset and s0
2 are properties that depend
on the camera hardware. With these parameters properly calibrated, we ob-
tained the distribution of the brightness of each individual pixel in the image
of the cell under investigation.VLP assays
Recently, it has been shown that in addition to VLP formation VP40 is
secreted from human cells by an unconventional mechanism (34). This
means that VLP assays must be properly controlled by measuring VP40
in VLPs and not a simple analysis of VP40 present in the cellular media
as an assessment of VLP formation. To quantify VLP formation, EGFP-
VP40, EGFP-VP40-WEA, or EGFP were detected with a GFP ELISA kit
(Cell Biolabs, San Diego, CA) according to the manufacturer’s protocols.
VLPs were isolated from A549 cellular media as previously described(25) 48-h posttransfection. Cells were collected and lysed to measure the
cellular concentration of EGFP-VP40, EGFP-VP40-WEA, or EGFP using
the BCA protein assay method as a control for total protein content.
Relative VLP formation is expressed as the ratio of EGFP in the VLPs/
EGFP in the cellular lysate. Experiments were run in triplicate from two
separate cellular experiments done on different days.RESULTS
Dynamic properties of VP40 in the cytosol and at
the plasma membrane
To date the dynamics of VP40 in live cells has not been
investigated. Thus, we used the RICS method to establish
how membrane association regulates the diffusion of
VP40. The RICS method (35) is particularly well suited
for this approach as it can be used to measure molecular
dynamics of fluorescently labeled molecules in live cells.
RICS is the ideal method for meeting these objectives as
the scanning movement creates a space-time matrix of
pixels within each image. From the stack of frames collected
for a live cell a spatial correlation map can be obtained to
determine a particle’s diffusion coefficient. Thus, when
the spatial correlation map is obtained at different subcel-
lular locales the diffusion coefficient can be determined at
different cellular sites. This provides information on how
the membranes, organelles, or other cellular components
restrict the movement of fluorescently labeled proteins.
VP40 has been shown to localize to the inner leaflet of
the plasma membrane where budding of the Ebola virus
occurs. We first sought to confirm the localization of
EGFP-VP40 and investigate the dynamics of VP40 when
localized to the plasma membrane. For these purposes
each cell expressing EGFP-VP40 was scanned with an
area of 256  256 pixels with a pixel dwell time of
12.6 ms for 100 frames. This allowed collection of a spatial
map of the cell with respect to time where expression of
EGFP alone was used as a control. To assess the dynamics
of VP40 in live cells, EGFP-VP40 diffusion (Fig. S1 in
the Supporting Material) was measured in the cytosol and
at the plasma membrane 24 h posttransfection and analyzed
as described previously (36). EGFP had a diffusion coeffi-
cient of 7.75 1 mm2 s1 and did not show any fluctuations
throughout the scan area nor were any changes detected at or
near membranes. Shown in Fig. 2, A–F, is the spatial corre-
lation map of VP40 in HEK293T cells, which indeed
showed a significant enrichment of VP40 on the plasma
membrane. The spatial correlation map was fit to a single
species diffusion model to determine the diffusion coeffi-
cient of VP40 in the cytoplasm and on the plasma
membrane. The diffusion properties of VP40 are summa-
rized in Fig. 2 I. The diffusion of VP40 in the cytosol
(2.8 5 0.4 mm2 s1) was slower than monomeric EGFP
(Fig. 2 I and Fig. S1). This is not unexpected as EGFP-
VP40 is 40 kDa larger than EGFP. EGFP-VP40 diffused
~22 times faster in the cytosol than on the plasma membraneBiophysical Journal 102(11) 2517–2525
FIGURE 2 RICS analysis of EGFP-VP40 expressed in HEK293T cells. RICS data were acquired by taking 100 frames (256 256 pixels at 0.05 mm/pixel)
at a scan speed of 12.60 ms/pixel. (A) A region of interest (White scale bar¼ 3.2 mm), 4.5 mm 4.5 mm (pink square box) in the cytosol was analyzed to yield
(B) the spatial autocorrelation map of the cytosol. (C) The spatial autocorrelation map is then fit to a single species diffusion model to determine the diffusion
coefficient of VP40 in the cytosol (2.85 0.4 mm2 s1). (D) Region of interest (white scale bar¼ 3.2 mm) at the plasma membrane from the same cell shown
in A is used to calculate (E) the spatial correlation map and (F) fit the spatial correlation map to a single species diffusion model to calculate the diffusion
coefficient of VP40 at the plasma membrane (0.13 5 0.06 mm2 s1). (G) The same cell shown in A and D (visualized as EGFP localization) is used to
create (H) a diffusion map of the VP40 transfected cell, where the color scale represents fast (red or darkest) or slow (blue or lightest) diffusion for the
4.5 mm  4.5 mm area highlighted in A. Here, the area of interest is fit to a single species diffusion model to investigate the change in diffusion coefficient
of EGFP-VP40 with respect to spatial localization. The fastest (or largest diffusion coefficients) moving particles are shown in red (darkest), whereas the
slowest (smallest diffusion coefficients) are shown in blue (lightest). (I) The diffusion coefficients determined for EGFP, EGFP-VP40 in the cytosol, and
EGFP-VP40 at the plasma membrane. VP40 exhibits 22-fold slower diffusion at the plasma membrane than in the cytosol.
2520 Adu-Gyamfi et al.(0.135 0.06 mm2 s1), which was expected due to restric-
tions imposed by the membrane. Furthermore, the decreased
diffusion may be attributed to membrane binding (37), olig-
omerization (22,25), or interaction with cellular components
(19) that have been previously reported. Taken together,
EGFP-VP40 is significantly enriched on the plasma
membrane of HEK293T cells where the diffusion is reduced
22-fold.Monomeric VP40 is recruited from the cytosol
to the plasma membrane
Infectious Ebola virus as well as VP40 alone assemble and
bud from the inner leaflet of the plasma membrane where
membrane association has been suggested to trigger oligo-
merization of VP40 (10). To investigate the assembly or
accumulation of EGFP-VP40 in live cells in real time, inten-Biophysical Journal 102(11) 2517–2525sity derivative analysis in the SimFCS program (www.lfd.
uci.edu) was used. Intensity derivative analysis allows inten-
sity fluctuations of fluorescently labeled proteins to be
monitored at different subcellular locations with respect to
time. Thus, to assess the accumulation of VP40 in the
cytosol and on the plasma membrane HEK293T cells
were scanned for 156 s to obtain plots of fluorescent fluctu-
ations at the plasma membrane and in the cytosol with
respect to time. There was a significant accumulation of
VP40 on the plasma membrane characterized by the
increase in fluorescent intensity as a function of time
(Fig. 3, C and D), compared to the cytosol where intensity
remained constant over the same time period (Fig. 3, A
and B). Taken together, these studies show VP40 is recruited
from the cytosol strengthening the notion that VP40
assembly occurs predominately on the plasma membrane.
It should also be noted that the transport of VP40 on
FIGURE 3 Recruitment of VP40 to the plasma
membrane. Analysis of cytosolic and membrane
regions of HEK293T cells expressing EGFP-
VP40 were done with RICS. (A) Average image
of cell showing region of analysis in the cytosol
(pink box). (B) Intensity derivative plot obtained
by analysis of intensity fluctuations in the cytosol
with respect to time. The total scan time was
156 s and thus the x axis represents a total time
of 156 s where linear tau represents time with 1
unit representing 3.12 s. (C) Average image
showing region of interest at a plasma membrane
VP40 bud site where three individual growing
bud sites are shown. (D) Intensity plot with respect
to time at the membrane. The total scan time was
156 s and thus the x axis represents a total time of
156 s where linear tau represents time with 1 unit
representing 3.12 s.
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alternative interpretation of the recruitment of VP40 to the
plasma membrane. Nonetheless, the VP40 bud sites
assemble on the plasma membrane as shown in Fig. 3 C.Oligomerization state of VP40 on the plasma
membrane
Although many reports have suggested that VP40 oligomer-
izes in the cell and even specifically on the plasma
membrane (18) the origin, true size, and subcellular location
of VP40 oligomers in live cells is still unknown. To under-
stand how oligomerization of VP40 varies with cellular
localization, a combination of TIRF microscopy and the
N&B analysis (31,38) were used to study the oligomeriza-
tion state of VP40 on the plasma membrane. Additionally,
N&B analysis was also done with confocal microscopy to
visualize VP40 oligomerization throughout the cell. N&B
analysis allows for measurement of the average number of
molecules as well as brightness in each pixel of a fluorescent
microscopy image. Thus, this method is well suited to
resolve the spatial distribution of VP40 oligomers in live
cells.
HEK293T cells were transfected with plasmids express-
ing either monomeric EGFP (N ¼ 5) or Ebola EGFP-
VP40 (N ¼ 7). The oligomerization state of VP40 was
assessed by analyzing the intrinsic brightness of proteins
in the cells. To calibrate for the monomeric state of the
proteins, HEK293T cells expressing EGFP were analyzed.The calibration using the brightness of a monomer allows
for the selection of oligomers, which are a multiple of the
brightness of the monomer. Thus, selection windows in
the brightness versus intensity plots can be used to select
the average brightness of each species of interest (monomer,
dimer, hexamer, etc.) to visualize the cellular localization of
each species. As shown in Fig. 4, A–D, we observed that
EGFP exists primarily as a monomer and hence did not
influence the oligomerization of VP40. N&B analysis of
EGFP-VP40 (Fig. 4, E–L), revealed that unlike free EGFP
(Fig. 4, A–D), it forms higher order structures as high as
16 mers localized on the plasma membrane (Fig. 4, I–L,
and Fig. S2, D and E). Although the frequency of oligomers
observed on the plasma membrane was significantly less
than the monomeric species (Fig. 4, G and H), oligomers
were highly enriched within filamentous structures
protruding from the plasma membrane (Fig. 4, J and L).
Sites of membrane protrusion were determined by visual
inspection of cells using TIRF microscopy (Fig. S3).
Expression of EGFP-VP40 but not EGFP alone in
HEK293T cells is characterized by a significant number
of membrane protrusions extending from the plasma
membrane of the cell. Hexamers and octamers of VP40,
the predominant oligomeric species of VP40 previously re-
ported (22–25), are found exclusively in these membrane
protrusion sites (Fig. 4, I–L). However, the predominant
species on the membrane were monomers (Fig. 4, F–H
and A), suggesting VP40 either associates with the plasma
membrane or is transported to the plasma membrane inBiophysical Journal 102(11) 2517–2525
FIGURE 4 Brightness analysis of VP40 and
EGFP in HEK293T cells. (A) TIRF intensity image
of a HEK293T cell transfected with plasmid ex-
pressing EGFP. (B) Brightness image of the same
cell shows the lack of EGFP clustering. (C) Bright-
ness versus intensity map for the EGFP expressing
cell with monomers highlighted by the red box. (D)
Selected pixels from C displaying the localization
of monomeric EGFP in red. (E) TIRF intensity
image of a HEK293T cell expressing EGFP-
VP40. (F) Brightness distribution of the VP40 ex-
pressing cell in E demonstrates enrichment of
EGFP-VP40 clustering on the plasma membrane.
Specifically, EGFP-VP40 is clustered at sites of
membrane protrusion that can also be viewed in
Fig. S3. (G) Brightness versus intensity map of
VP40 showing monomers (red box or lower box),
trimers (blue box or middle box), and octamers
(green box or upper box). (H) Selected pixels
from G showing monomers (red), trimers (blue),
and octamers (green). The majority of VP40 local-
ized to the plasma membrane is present in the
monomeric form. (I) Brightness versus intensity
plot displaying hexamers (red box or lower box)
and octamers (blue box or upper box). (J) Bright-
ness distribution of VP40 with selected pixels
displaying hexamers (red) and octamers (blue), which are significantly enriched at sites of membrane protrusions. (K) Brightness versus intensity
plot displaying 16 mers (red box). (L) Image of the cell showing pixels with brightness of 16 mers (red) localized at sites of membrane protrusion. White
scale bar ¼ 18 mm on all panels.
2522 Adu-Gyamfi et al.a monomeric form where oligomerization is then triggered
through membrane association as previously suggested
(10). Additionally, other cellular components should be
considered such as protein-protein interactions, VP40 cyto-
skeleton interactions, or VP40 interaction with a specific
lipid such as phosphatidylserine (PS) or phosphatidylinosi-
tol-3,4,5-trisphosphate, which are enriched on the inner
leaflet of the plasma membrane.
N&B analysis was also performed using the confocal
image stacks acquired from RICS analysis of HEK293T
cells expressing either EGFP (Fig. S1) or EGFP-VP40
(Fig. S2). In consonance with the TIRF imaging data,
VP40 oligomers were highly enriched on the plasma
membrane (Fig. S2, D and E), when compared to other
cellular sites. This underscores the unique localization of
VP40 oligomers to sites of membrane protrusion from the
plasma membrane.
To control for nonspecific oligomerization of VP40 we
employed a double mutant control of the VP40 intradimeric
interface (W95A/E160A or VP40-WEA), which has been
shown to abolish VP40 oligomerization and diminish egress
(22). EGFP-VP40-WEA displayed a similar cytosolic diffu-
sion coefficient as wild-type EGFP-VP40 but did not display
detectable oligomers (Fig. S4, E and F). Additionally, sites
of membrane protrusion were no longer visible (Fig. S4, A,
B, D, and F) in EGFP-VP40-WEA transfected cells consis-
tent with a recent study that showed VP40-WEA signifi-
cantly reduced viral egress (22). A frequency versus
apparent brightness plot for EGFP (Fig. 5 A), EGFP-VP40Biophysical Journal 102(11) 2517–2525(Fig. 5 B), or EGFP-VP40-WEA (Fig. 5 C) expressing cells
further demonstrates the specific and significant oligomeri-
zation of EGFP-VP40 compared to EGFP-VP40-WEA or
EGFP controls. As shown in Fig. 5 D VP40-WEA sig-
nificantly reduced VLP formation compared to wild-type
VP40, which is consistent with the loss of filamentous sites
of viral egress (Fig. S4, A, D, and F) as well as previous
studies demonstrating the role of oligomerization in
VP40-mediated exit (22,25).DISCUSSION
Oligomerization of VP40 represents a crucial step in the
assembly of the Ebola virus (22,23,37,39). Inhibition of
this step of the viral life cycle has been found to downregu-
late the formation and release of new virions and VLPs
(22,25). It has also been shown that in the absence of
VP40, recruitment of viral proteins to the membrane is in-
hibited (17). Hence, understanding the cellular mechanisms
behind VP40 oligomerization is necessary to deepen our
understanding of filovirus assembly. To date, VP40 oligo-
merization has been studied using cell lysates or purified
membranes from transfected or infected cells (18) as well
as in vitro using cross-linking experiments (24,39).
Although these studies have been useful in expanding the
mechanism of Ebola assembly, they are not able to funda-
mentally address how the protein assembles within the
cell in a real-time manner. Furthermore, in vitro studies
that attempted to resolve oligomeric states were carried
FIGURE 5 Correlation of VP40 and VP40-
WEA apparent brightness and frequency as well
as VLP egress. (A) Frequency versus apparent
brightness plot for monomeric EGFP, (B) EGFP-
VP40, and (C) EGFP-VP40 WE-A from
HEK293T cells. These plots show the frequency
(pixels) of VP40 oligomerization in comparison
to VP40 WE-A. (D) VLPs were detected with
anti-EGFP antibody to compare the release of
EGFP-VP40 and EGFP-VP40-WEA VLPs. Cells
transfected with EGFP were used as a control for
background EGFP detection. Results are plotted
as a ratio of EGFP in the VLPs/EGFP in the cell
lysate. Three trials were run for each condition
from two separate experiments of VLP and cell
lysate collection. (E) A model proposing the local-
ization of VP40 oligomers. Imaging data from both
confocal and TIRF microscopy support the notion
that VP40 is predominantly monomeric in the
cytoplasm as well as when associated with the
plasma membrane. Plasma membrane association
of VP40 then may be able to induce the oligomer-
ization of VP40 into dimers and trimers, which are
also predominantly associated with the plasma membrane. Higher order VP40 oligomers (hexamers and octamers for instance), which have been shown to
exist in infectious Ebola virions are highly enriched in membrane protrusions emanating from the plasma membrane. (See the Discussion section for a more
critical discussion of the factors that may regulate VP40 assembly and oligomerization).
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of the assembly process. Hence, the ability to resolve the
assembly and oligomeric state of VP40 in a real-time nonin-
vasive biologically relevant fashion is essential to moving
the investigation of filovirus assembly forward. In this
report, we have resolved the oligomeric state of Ebola
VP40 using RICS analysis and TIRF microscopy coupled
with the N&B method.
First, we demonstrated that VP40 has different dynamic
properties in the cytosol and on the membrane. Using
RICS, we determined the diffusion coefficient of EGFP-
VP40 is reduced 22-fold on the membrane compared to
the cytosol. The decrease in diffusion coefficient could
certainly be attributed to membrane association, which is
interesting as VP40 binds the lipid PS with nanomolar
affinity (E. Adu-Gyamfi and R. V. Stahelin, unpublished
results) and PS is enriched at the inner leaflet of the plasma
membrane. In addition, other regulatory factors such as
VP40-protein interactions or VP40-cytoskeleton interac-
tions at the plasma membrane should also be considered.
Intensity derivative analysis, which computes changes in
intensity of the diffusing fluorophores at the pixel level,
demonstrated that on the membrane the VP40 intensity
increases as a function of time despite any photobleaching
effects. However, under the same conditions EGFP-VP40
intensity in the cytosol remained constant. These data sug-
gested VP40 assembles on the plasma membrane. Consis-
tent with this notion VP40 has previously been shown to
undergo a conformational change upon membrane binding
(37), which has been proposed to trigger its oligomerization
(10). Motivated by this suggestion and the observation
that aggregates of VP40 were found to be associated withdetergent-resistant membranes (18) we studied the localiza-
tion of VP40 oligomers on the plasma membrane and
throughout the cell. Our results show that although oligo-
mers of VP40 were detected on the plasma membrane a
significant proportion of plasma membrane-associated
VP40 was monomeric. This is not particularly surprising
if the monomers are continuously being recruited from the
cytosol (Fig. 5 E) to serve as building blocks for self-multi-
merization into hexamers required for viral egress (25) and
octamers required for RNA binding (22,24). How then is
VP40 recruited to the plasma membrane? Nanomolar
affinity of VP40 for PS is certainly one possibility. Addi-
tionally, VP40 may also have significant affinity for other
lipids or proteins enriched at the inner leaflet of the plasma
membrane. In addition, transport of VP40 on vesicles of
similar composition to the plasma membrane is also a
possibility.
We also observed that oligomers (hexamers, octamers,
and larger oligomers) were found enriched at the tips of the
cells in filamentous protruding structures (Fig. 4, I and J).
Filamentous protrusion sites are consistent with sites of
viral egress for Ebola (17) and Marburg virus (40). In further
support of localization of VP40 oligomers in sites of
membrane protrusion, VP40-WEA, which abrogates oligo-
merization diminished detectable membrane protrusion
sites. To the best of our knowledge larger oligomers of
VP40 have not been previously reported and the nature and
role of these larger oligomers in VP40-mediated assembly
remain unknown. Large oligomers have been observed to
be essential to the membrane deforming activity of lipid
binding domains such as BAR (41) and ENTH (42) domains
and could play a role in Ebola-mediated egress throughBiophysical Journal 102(11) 2517–2525
2524 Adu-Gyamfi et al.formation of a lattice as proposed for other lipid enveloped
viruses (28). It may also suggest that VP40 molecules in
the cell are organized into larger structures that are beyond
the resolution detectable by cross-linking assays. However,
it is possible these large oligomers do not have significant
mechanistic consequences in the Ebola life cycle and
clearly further analysis of these structures will be necessary.
Nonetheless, we believe our analysis is suitable for
detecting the presence of VP40 oligomers in cells and offers
superior detection and resolution compared to previous
analysis from cell lysates and in vitro cross-linking
assays (18,22). First, our analysis takes into account
oligomerization within the cell in real time while avoiding
the use of harsh conditions such as detergent solubilization
and excessive heat that may disrupt oligomers. Second,
in vivo or in vitro cross-linking may result in nonspecific
cross-links further complicating the analysis. Third, the
inherent sensitivity of our methods makes it possible to
obtain high spatial resolution images elucidating the distri-
bution of oligomers in the cells at different time points.
One drawback to this assay is the necessary tagging of
VP40 with EGFP. However, we demonstrate EGFP-VP40
robustly produces VLPs offering the ability to study single-
molecule interactions with fluorescently labeled host cell
factors in the future.
In conclusion, we have detected the oligomeric states of
Ebola VP40 in a biologically relevant and noninvasive
system using TIRF microscopy that selectively excites
membrane resident molecules. We found that VP40 oligo-
mers are found primarily in filamentous plasma membrane
protrusion sites. Interestingly, the majority of VP40 proteins
on the membrane are monomers suggesting that monomeric
VP40 is recruited from the cytosol or trafficked on transport
vesicles to serve as building blocks for multimerization.
VP40-mediated oligomerization then either induces or is
localized to plasma membrane protrusion sites, where
viral egress occurs (Fig. 5 E). The main determinant of
VP40-mediated oligomerization is still unknown and it is
tempting to propose that high affinity of VP40 for an en-
riched plasma membrane component such as PS is suffi-
cient to induce oligomerization. Indeed, PS is able to
induce significant oligomerization of VP40 in an in vitro
cross-linking assay compared to other anionic lipids
(E. Adu-Gyamfi and R. V. Stahelin unpublished results).
Clearly, the investigation of specific VP40-lipid and
VP40-protein interactions at the plasma membrane is of
utmost interest as these interactions may serve as pharma-
cological targets to inhibit Ebola budding and egress. In
closing, application of single molecule studies using both
confocal and TIRF microscopy was essential to investi-
gating the real-time assembly and egress of Ebola VP40
as similarly demonstrated for HIV (43–45). These tech-
niques hold much promise for building a spatio temporal
map of the host cell factors required for VP40-mediated
assembly and egress on the plasma membrane.Biophysical Journal 102(11) 2517–2525SUPPORTING MATERIAL
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